Literature DB >> 15915493

Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.

Alyssa M Krasinskas1, Bijan Eghtesad, Patrick S Kamath, Anthony J Demetris, Susan C Abraham.   

Abstract

Intrahepatic noncirrhotic portal hypertension can be idiopathic or associated with known toxic, developmental, vascular, or biliary tract diseases. Most patients are successfully managed medically or with shunting procedures. The goal of this study was to explore the reasons some patients require orthotopic liver transplantation (OLT). The clinical features, gross and microscopic liver explant pathology, and posttransplantation course in 16 patients who underwent OLT for intrahepatic noncirrhotic portal hypertension were studied. There were 11 men and 5 women with a mean age of 47 years. Clinical manifestations included gastrointestinal varices (n = 12), ascites (n = 8), encephalopathy (n = 3), and hepatopulmonary syndrome (n = 3). Cirrhosis was misdiagnosed clinically, radiographically and/or histologically in 13 patients (81%). Grossly, liver explants weighed a mean of 1,100 g, and 12 had a nodular appearance. Histologically, all 16 livers had portal tract vascular abnormalities, 15 had nodular regenerative hyperplasia (NRH), and 9 had incomplete septal cirrhosis. After OLT, mild NRH features were noted in 2 patients, and 1 of these patients developed evidence of portal hypertension. This study demonstrates that a subset of patients with intrahepatic noncirrhotic portal hypertension have severe symptoms requiring OLT. Accurate pre-OLT diagnosis is frequently difficult at advanced stages of the disease; 81% of our patients carried a diagnosis of cirrhosis. Morphologically, the explanted livers showed evidence of vascular abnormalities, NRH, and increased fibrosis, but not cirrhosis. Importantly, however, a diagnosis of cirrhosis is not required in this group of patients to qualify them for OLT, and these patients have good long-term graft function after OLT.

Entities:  

Mesh:

Year:  2005        PMID: 15915493     DOI: 10.1002/lt.20431

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  35 in total

1.  Noncirrhotic portal fibrosis: a rare cause of end-stage liver disease requiring liver transplantation.

Authors:  Sunil Taneja; Yogesh Chawla; Radha K Dhiman
Journal:  Hepatol Int       Date:  2011-09-03       Impact factor: 6.047

2.  Implications of portal vein thrombosis after splenectomy for patients with idiopathic portal hypertension.

Authors:  Teijiro Hirashita; Masayuki Ohta; Seiichiro Kai; Takashi Masuda; Hidetoshi Eguchi; Yukio Iwashita; Tadashi Ogawa; Seigo Kitano
Journal:  Surg Today       Date:  2011-10-04       Impact factor: 2.549

3.  Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors.

Authors:  C E Eapen; Peter Nightingale; Stefan G Hubscher; Peter J Lane; Timothy Plant; Dimitris Velissaris; Elwyn Elias
Journal:  Dig Dis Sci       Date:  2010-05-25       Impact factor: 3.199

4.  Hepatobiliary quiz-12 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12

5.  Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography.

Authors:  Yoshihiro Furuichi; Fuminori Moriyasu; Junichi Taira; Katsutoshi Sugimoto; Takatomo Sano; Shigeki Ichimura; Yuki Miyata; Yasuharu Imai
Journal:  J Gastroenterol       Date:  2012-11-10       Impact factor: 7.527

6.  Association of celiac disease and portal hypertension: Cirrhotic or noncirrhotic.

Authors:  Bir Singh; Paras Shah; M Rajmani; Rupesh Kumar Pokharna; Prachis Ashdhir; Subhash Nepalia
Journal:  Indian J Gastroenterol       Date:  2015-01

7.  Noncirrhotic intrahepatic portal hypertension: towards a unifying definition and etiology.

Authors:  B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2014-05-31

8.  Idiopathic non-cirrhotic intrahepatic portal hypertension: common cause of cryptogenic intrahepatic portal hypertension in a Southern Indian tertiary hospital.

Authors:  Kadiyala Madhu; Balekuduru Avinash; Banumathi Ramakrishna; C E Eapen; N K Shyamkumar; Uday Zachariah; George Chandy; George Kurian
Journal:  Indian J Gastroenterol       Date:  2009-11-12

9.  Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension.

Authors:  Azusa Kitao; Yasunori Sato; Seiko Sawada-Kitamura; Kenichi Harada; Motoko Sasaki; Hiroyasu Morikawa; Susumu Shiomi; Masao Honda; Osamu Matsui; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

10.  Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.

Authors:  Florian Bihl; Filip Janssens; Francoise Boehlen; Laura Rubbia-Brandt; Antoine Hadengue; Laurent Spahr
Journal:  BMC Gastroenterol       Date:  2010-01-18       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.